Vimarsana
Biggest News Aggregation in the World

Page 6 - Elitech Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Elitech Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Elitech Group Today - Breaking & Trending Today

Monogenic Disease Testing Market to Grow at a Surprising CAGR Growth of 11% by 2029, Growth Prospects, Size, Share, Trend and Opportunity Assessment - Vimarsana News

Monogenic Disease Testing Market to Grow at a Surprising CAGR Growth of 11% by 2029, Growth Prospects, Size, Share, Trend and Opportunity Assessment

/PRNewswire/ -- Data Bridge Market Research Published Latest Monogenic Disease Testing Market Study by in-depth analysis about current scenario, the Market...

The Worldwide Antimicrobial Susceptibility Testing Industry is Expected to Reach $4.9 Billion by 2027 - Vimarsana News

The Worldwide Antimicrobial Susceptibility Testing Industry is Expected to Reach $4.9 Billion by 2027

/PRNewswire/ -- The "Global Antimicrobial Susceptibility Testing Market (2022-2027) by Product, Type, Applications, Methods, End Users, Geography, Competitive...

Insights on the Antimicrobial Susceptibility Testing Global - Vimarsana News

Insights on the Antimicrobial Susceptibility Testing Global

Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Antimicrobial Susceptibility Testing Market (2022-2027) by Product, Type, Applications, Methods,...

InfanDx, EliTech Group Partner on Hypoxic-Ischemic Encephalopathy Test - Vimarsana News

InfanDx, EliTech Group Partner on Hypoxic-Ischemic Encephalopathy Test

Under the terms of the deal, InfanDx will develop the test with EliTech providing contract manufacturing support.

Source: 360dx.com
Fungal Testing Kits Market is set to experience a significant growth of 10.4% CAGR from 2022 to 2030 - Vimarsana News

Fungal Testing Kits Market is set to experience a significant growth of 10.4% CAGR from 2022 to 2030

Growing prevalence of superficial and systemic fungal infections have posed a significant challenge to healthcare providers across the world. Increasing prevalence of fungal infections of the skin, vagina and blood have prompted vendors to concentrate on developing swift and advanced molecular diagnostics in recent...